L-Methylfolate is the body's active folate, used directly and reaching the brain. It reliably improves folate status and lowers homocysteine, and clearly helps those with a common gene variant that slows folate activation. Mood, heart, and brain-aging benefits are modest or unproven. The most important cautions are confirming vitamin B12 first and raising the dose gradually. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Homocysteine | 5–8 µmol/L | Primary target reflecting methylation and folate/B12 sufficiency |
| Serum vitamin B12 | > 500 pg/mL | Safety gate; low B12 both blunts benefit and can be masked by folate |
| Methylmalonic acid (MMA) | < 0.27 µmol/L | Confirms true B12 sufficiency when serum B12 is borderline |
| Red-blood-cell folate | > 400 ng/mL | Reflects long-term folate stores rather than recent intake |
| Serum folate | 10–20 ng/mL | Confirms recent folate intake and absorption |
| Complete blood count / MCV | MCV 85–90 fL | Detects large-cell (macrocytic) anemia of folate or B12 deficiency |
| MTHFR genotype (optional, one-time) | Informational | Identifies variant carriers who may favor the methyl form |
Cadence: Baseline before starting; recheck homocysteine at 8–12 weeks; then reassess homocysteine and B12 every 6–12 months, more often in older adults or those at risk of B12 deficiency